Lymphangioleiomyomatosis
📧 Sign up to get email alerts when something new happens for Lymphangioleiomyomatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1) [Phase 1]
This Phase 1 trial assesses the tolerability of Saracatinib in subjects with lymphangioleiomyomatosis, and the study status is completed.
-
CLINICAL_TRIALS research · 2016-02-18Clinical Trial Update: Lymphangioleiomyomatosis (LAM) Registry
An update on the Lymphangioleiomyomatosis (LAM) patient registry sponsored by NHLBI; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-12-11Clinical Trial Update: Pulmonary Rehabilitation in Lymphangioleiomyomatosis [NA]
The clinical trial evaluating pulmonary rehabilitation in lymphangioleiomyomatosis has been completed.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Doxycycline In Lymphangioleiomyomatosis (LAM) [Phase 4]
Phase 4 trial of doxycycline in lymphangioleiomyomatosis (LAM) has been completed, including cases associated with tuberous sclerosis comple…
-
CLINICAL_TRIALS trial_result · 2013-09-25Clinical Trial Update: RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the mTOR inhibitor everolimus (RAD001) for angiomyolipomata in patients with tuberous sclerosis complex and spor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) [Phase 1, Phase 2]
Long-term follow-up results for everolimus (RAD001) therapy in patients with tuberous sclerosis complex-associated angiomyolipoma and sporad…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) [Phase 3]
Phase 3 trial assessing the efficacy and safety of everolimus (RAD001) in adults with angiomyolipoma associated with tuberous sclerosis comp…
-
CLINICAL_TRIALS trial_result · 2011-10-27Clinical Trial Update: Pulmonary Hypertension in Lymphangioleiomyomatosis
A clinical trial evaluating pulmonary hypertension in lymphangioleiomyomatosis has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-30Clinical Trial Update: Treatment With Octreotide in Patients With Lymphangioleiomyomatosis [Phase 2]
A Phase 2 trial evaluating octreotide in patients with lymphangioleiomyomatosis was completed, with results posted in 2010. The sponsor was …
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM [Phase 2]
Phase 2 trial evaluating the efficacy and safety of sirolimus in tuberous sclerosis complex and lymphangioleiomyomatosis.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)
Official clinical trials record indicating a completed study related to lymphangioleiomyomatosis (LAM).
-
CLINICAL_TRIALS trial_result · 2007-04-09Clinical Trial Update: Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM [Phase 2]
Phase 2 clinical trial update reports on rapamycin therapy for patients with tuberous sclerosis complex and sporadic lymphangioleiomyomatosi…